Altus Wealth Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,995
Closed -$203K 141
2025
Q1
$203K Sell
7,995
-299
-4% -$7.82K 0.09% 128
2024
Q4
$220K Sell
8,294
-1,143
-12% -$31K 0.1% 133
2024
Q3
$273K Buy
9,437
+204
+2% +$5.95K 0.12% 119
2024
Q2
$258K Sell
9,233
-1,485
-14% -$40.9K 0.13% 114
2024
Q1
$297K Sell
10,718
-839
-7% -$23.3K 0.15% 112
2023
Q4
$333K Sell
11,557
-1,198
-9% -$36.2K 0.18% 107
2023
Q3
$423K Buy
12,755
+2
+0% +$71 0.27% 84
2023
Q2
$468K Sell
12,753
-710
-5% -$27.6K 0.29% 82
2023
Q1
$549K Sell
13,463
-13
-0.1% -$561 0.37% 69
2022
Q4
$691K Sell
13,476
-99
-0.7% -$4.75K 0.52% 51
2022
Q3
$584K Hold
13,575
0.58% 48
2022
Q2
$584K Buy
13,575
+3
+0% +$153 0.58% 48
2022
Q1
$703K Sell
13,572
-8
-0.1% -$415 0.58% 38
2021
Q4
$802K Buy
13,580
+5
+0% +$248 0.66% 37
2021
Q3
$584K Sell
13,575
-2,772
-17% -$123K 0.58% 48
2021
Q2
$640K Buy
16,347
+193
+1% +$7.5K 0.63% 37
2021
Q1
$645K Buy
16,154
+3,588
+29% +$127K 0.64% 35
2020
Q4
$463K Buy
+12,566
New +$461K 0.44% 44

Other funds holding PFE

Altus Wealth Group's PFE Position: Q2 2025 in Review

Altus Wealth Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 7,995 shares — an estimated $203K sold.

Altus Wealth Group first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $802K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Altus Wealth Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Altus Wealth Group sold 7,995 Pfizer shares in Q2 2025, an estimated $203K.
  • Altus Wealth Group first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
  • Altus Wealth Group's Pfizer position peaked at $802K in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Altus Wealth Group's 13F filing for Q2 2025, filed 29 Jul 2025.